Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adriforant in moderate to severe plaque psoriasis
NCT02618616Phase 2Completed
- Sponsor
- Ziarco Pharma Ltd
- Start
- Jan 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of adriforant in plaque psoriasis, sponsored by Ziarco Pharma Ltd. Started Jan 2016; status: completed.
02
Drugs
adriforant
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02618616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02618616.